Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Abagovomab | Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc) [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-Human CA-125 Recombinant Antibody. CAS No. 792921-10-9. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P99276. |  |
| Abatacept | Abatacept (CTLA4lg) is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains) [1]. Abatacept is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases [1] [2] [3]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: CTLA4lg; BMS-188667. CAS No. 332348-12-6. Pack Sizes: 1 mg; 5 mg. Product ID: HY-108829. | |
| Abatacept (powder) | Abatacept (CTLA4lg; BMS-188667) powder is a soluble fusion protein consisting of the extra-cellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains). Abatacept powder is a selective T-cell co-stimulation modulator and a protein agent for the autoimmune diseases [1] [2] [3]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: CTLA4lg (powder); BMS-188667 (powder). CAS No. 332348-12-6. Pack Sizes: 1 mg; 5 mg. Product ID: HY-108829A. | |
| Abciximab | Abciximab (C7E3), a chimeric mouse/human monoclonal antibody fragment, is a glycoprotein (GP) IIb/IIIa inhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein IIb/IIIa, vitronectin and Mac-1 receptors [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: C7E3. CAS No. 143653-53-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9934. | |
| Abelacimab | Abelacimab (MAA868) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MAA868. CAS No. 2098724-83-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99415. | |
| Abiprubart | Abiprubart is an anti- CD40 human IgG4 κ monoclonal antibody [1]. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003). Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 2765071-95-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990726. | |
| Abituzumab | Abituzumab (DI17E6) is a humanised anti- integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK , Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: EMD 525797; DI17E6. CAS No. 1105038-73-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99183. | |
| Abrilumab | Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD) [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 1342290-43-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99184. | |
| Acapatamab | Acapatamab (AMG-160) is an anti- CD3E/FOLH1 monoclonal antibody [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: AMG-160. CAS No. 2314491-93-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99418. | |
| Acasunlimab | Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. Acasunlimab enhances T-cell and NK-cell function through conditional 4-1BB stimulation while constitutively blocking the PD-1/PD-L1 inhibitory axis. Acasunlimab can be used in research of cancer [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: GEN1046. CAS No. 2253937-12-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99419. | |
| ACT017 | ACT017 is a Fab fragment of humanized anti- GPVI monoclonal antibody. ACT017 inhibits collagen-induced platelet aggregation. ACT017 has the potential for the research of acute ischemic stroke [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 2101829-58-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99644. | |
| Actoxumab | Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab (HY-P9929) targeting TcdB [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-C. difficile Toxin A Recombinant Antibody. CAS No. 1245634-25-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99277. | |
| Adakitug | Adakitug (BMS-986253) is a CHO-expressed human antibody targeting CXCL8/IL-8. Adakitug contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 144.94 kDa. The isotype control for Adakitug can refer to Human IgG1 kappa, Isotype Control (HY-P99001). Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: BMS-986253; HuMax-IL-8. CAS No. 2231258-73-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990598. | |
| Adalimumab | Adalimumab is a human monoclonal IgG1 antibody targeting tumour necrosis factor?α ( TNF-α ). Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-Human TNF-alpha, Human Antibody. CAS No. 331731-18-1. Pack Sizes: 1 mg; 5 mg; 25 mg; 50 mg. Product ID: HY-P9908. | |
| ADC Control Human IgG1-Deruxtecan (DAR 4) | ADC Control Human IgG1-Deruxtecan (DAR 4) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E)[1]. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-164152. | |
| ADC Control Human IgG1-vcMMAE | ADC Control Human IgG1-vcMMAE is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-vcMMAE and can inhibit tubulin polymerization. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is vcMMAE (HY-15575)[1]. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg. Product ID: HY-164153. | |
| ADC Control Human IgG1-vcMMAF | ADC Control Human IgG1-vcMMAF is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-vcMMAF and can inhibit tubulin polymerization. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is MC-Val-Cit-PAB-MMAF (vcMMAF; HY-112786)[1]. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-164154. | |
| Adebrelimab | Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 ( PD-1/PD-L1 ) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC) [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: SHR-1316. CAS No. 2247114-85-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99422. | |
| Adecatumumab | Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MT 201; Anti-Human EPCAM Recombinant Antibody. CAS No. 503605-66-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99278. | |
| Adintrevimab | Adintrevimab (ADG 20) is a human IgG1 monoclonal SARS-CoV ( SARS-CoV ) antibody. Adintrevimab inhibits SARS-CoV-2 variants and other SARS-like coronaviruses with pandemic potential [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: ADG 20. CAS No. 2516243-54-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99423. | |
| Aducanumab | Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: BIIB037. CAS No. 1384260-65-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9967. | |
| Afelimomab | Afelimomab (MAK 195F) is an anti-tumor necrosis factor F(ab')2 monoclonal antibody fragment. Afelimomab can be used for the research of sepsis [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MAK 195F. CAS No. 156227-98-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99425. | |
| Afimkibart | Afimkibart (PF-06480605) is a human IgG1 monoclonal antibody targeting tumor necrosis factor-like ligand 1A (TL1A). Afimkibart can be used in the research of inflammatory bowel disease[1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: PF-06480605; RVT-3101. CAS No. 2911580-96-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990876. | |
| Aflibercept | Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR 1 and VEGFR 2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease [1] [2] [3]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: VEGF Trap; VEGF-TRAPR1R2; VEGF-trapR1. CAS No. 862111-32-8. Pack Sizes: 500 μg; 1 mg; 5 mg. Product ID: HY-108801. | |
| Aflibercept (VEGF Trap) | Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR 1 and VEGFR 2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease [1] [2] [3]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 862111-32-8. Pack Sizes: 500 μg; 1 mg; 5 mg. Product ID: HY-108801A. | |
| AFM24 | AFM24 is a bispecific antibody with a TandAb structure expressed in CHO, targeting EGFR&Fc-gamma-RIIIA. AFM24 contains a huIgG1-SCFV heavy chain and a ? light chain, with a predicted molecular weight (MW) of 74.5 kDa. The isotype control for AFM24 can refer to Human IgG1 kappa, Isotype Control (HY-P99001). Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990314. | |
| Aldafermin | Aldafermin (NGM282) is an analog of fibroblast growth factor 19. Aldafermin can be used for the research of nonalcoholic steatohepatitis (NASH) [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: NGM282. CAS No. 1616639-03-2. Pack Sizes: 500 μg; 1 mg. Product ID: HY-P99428. | |
| Alefacept | Alefacept (BG 9273) is a human lymphocyte function-associated antigen 3/immunoglobulin 1 fusion protein. Alefacept can be used for the research of chronic plaque psoriasis [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: BG 9273; Human LFA 3IgG fusion protein; LFA 3TIP. CAS No. 222535-22-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99429. | |
| Alemtuzumab | Alemtuzumab (Campath-IH) is a humanized monoclonal antibody against CD52. Alemtuzumab does not cross-react with murine CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. Alemtuzumab is capable of complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC), as well as induction of apoptosis. Alemtuzumab has the potential for B-cell chronic lymphocytic leukaemia research [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Campath-IH. CAS No. 216503-57-0. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P9948. | |
| Alirocumab | Alirocumab is an anti-PCSK9 human monoclonal antibody. Alirocumab inhibits PCSK9. Alirocumab reduces NLRP3 inflammasome , regulates Nrf2/HO-1 , HMGB1/NF-κB and Fractalkine/CX3CR1. Alirocumab increases the ability of the liver to bind LDL-cholesterol (LDL-C) and reduces levels of LDL-C in blood. Alirocumab improves atherosclerosis and inflammation [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: REGN 727; SAR 236553. CAS No. 1245916-14-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9928. | |
| Alirocumab (anti-PCSK9) | Alirocumab (anti-PCSK9) is an anti-PCSK9 human monoclonal antibody. Alirocumab (anti-PCSK9) inhibits PCSK9. Alirocumab (anti-PCSK9) reduces NLRP3 inflammasome , regulates Nrf2/HO-1 , HMGB1/NF-κB and Fractalkine/CX3CR1. Alirocumab (anti-PCSK9) increases the ability of the liver to bind LDL-cholesterol (LDL-C) and reduces levels of LDL-C in blood. Alirocumab (anti-PCSK9) improves atherosclerosis and inflammation [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: REGN 727(anti-PCSK9); SAR 236553(anti-PCSK9). CAS No. 1245916-14-6. Pack Sizes: 1 mg; 2 mg; 5 mg. Product ID: HY-P9928A. | |
| Alnuctamab | Alnuctamab (EM901) is an asymmetric 2-arm, humanized IgG T-cell engager (TCE). Alnuctamab can be used for immune research, serving as a B-cell maturation antigen (BCMA) x CD3 T-cell engager (TCE). Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: EM901; CC-93269. CAS No. 2296827-07-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99430. | |
| Alsevalimab | Alsevalimab is a human monoclonal antibody against B7-H4 [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 2254029-91-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99242. | |
| Amatuximab | Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MORab-009. CAS No. 931402-35-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99006. | |
| Amivantamab | Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: JNJ-61186372. CAS No. 2171511-58-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9977. | |
| Amlitelimab | Amlitelimab () is an anti- OX40 Ligand (OX40L) monoclonal antibody (mAb). Amlitelimab inhibits OX40-OX40L interaction, and can be used in the research of atopic dermatitis [1] [2] [3]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: KY1005; SAR445229. CAS No. 2378692-15-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99434. | |
| Amubarvimab | Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein , with a K D of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: BRII-196. CAS No. 2509447-07-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99435. | |
| Anbenitamab | Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting extracellular domains II and IV of human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathways. Anbenitamab mediates antibody-dependent cellular cytotoxicity (ADCC) via Fc?IIIa binding. Ambrinitumab can be used in research for lung cancer, HER2-positive metastatic breast cancer (MBC), gastric cancer, and gastroesophageal junction cancer[1][2][3][4]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: KN-026. CAS No. 2367012-88-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99437. | |
| Andecaliximab | Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 ( MMP9 ). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF) [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-MMP9 Reference Antibody (andecaliximab). CAS No. 1518996-49-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99351. | |
| Anetumab | Anetumab (Anti-MSLN Antibody) is an anti-mesothelin ( MSLN ) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-MSLN Antibody. CAS No. 1954758-84-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99352. | |
| Anifrolumab | Anifrolumab is a type I interferon ( IFN ) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 1326232-46-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99168. | |
| Anrukinzumab | Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma [1] [2] [3]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: IMA-638. CAS No. 910649-32-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99439. | |
| Anselamimab | Anselamimab (CAEL-101) a humanized IgG1-κ anti-Amyloid fibrils antibody targeting to serum amyloid A1 ( SAA1 ) [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: CAEL-101. CAS No. 2414866-63-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99105. | |
| Ansuvimab | Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Ansuvimab-zyk; mAb114. CAS No. 2375952-29-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99337. | |
| Anti-CD71/TfR1 Antibody | Anti-CD71/TfR1 Antibody (JR-141 antibody (uncoupled from iduronate 2-sulfatase)) is a humanized anti-human transferrin receptor (CD71; TfR) antibody. Anti-CD71/TfR1 Antibody is the antibody part of the fusion protein Pabinafusp alfa (HY-P99797). The recommend isotype control of Anti-CD71/TfR1 Antibody: Human IgG1 kappa, Isotype Control (HY-P99001)[1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: JR-141 antibody (uncoupled from iduronate 2-sulfatase). Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P991047. | |
| Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) | Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is the anti-DLL3 arm of the bispecific T-cell engager (BiTE) antibody-Tarlatamab (AMG-757) (HY-P99575). Tarlatamab targets both DLL3 and CD3. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990104. | |
| Anti-ENPP3/CD203c Antibody (AGS-16C3F antibody) | Anti-ENPP3/CD203c Antibody (AGS-16C3F antibody) is a humanized antibody expressed in CHO cells, targeting ENPP3/CD203c. Anti-ENPP3/CD203c Antibody contains a huIgG2 heavy chain and a hu? light chain, with a predicted molecular weight (MW) of 154.04 kDa. The isotype control for Anti-ENPP3/CD203c Antibody can refer to Human IgG2 kappa, Isotype Control (HY-P99002). Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: AGS-16C. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990315. | |
| Anti-EphA2 Antibody (1C1) | Anti-EphA2 Antibody (1C1) (MEDI-547 antibody) is a humanized antibody expressed in CHO cells, targeting EphA2. Anti-EphA2 Antibody (1C1) contains huIgG1 type heavy chain and hu? type light chain, with a predicted molecular weight (MW) of 146.68 kDa. The isotype control for Anti-EphA2 Antibody (1C1) can refer to Human IgG1 kappa, Isotype Control (HY-P99001). Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MEDI-547 antibody. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990627. | |
| Anti-GREM1/Gremlin Antibody | The Anti-GREM1/Gremlin Antibody is a humanized antibody expressed in CHO that targets GREM1/Gremlin. The Anti-GREM1/Gremlin Antibody has a huIgG4SP heavy chain and a hu? light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for the Anti-GREM1/Gremlin Antibody can refer to Human IgG4 kappa, Isotype Control (HY-P99003). Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990426. | |
| Anti-Mouse IFN gamma Antibody (H22) | Anti-Mouse IFN gamma Antibody (H22) is an anti-mouse IFN gamma IgG antibody inhibitor derived from host Armenian Hamster. Anti-Mouse IFN gamma Antibody (H22) abrogates specific binding of I25II-rIFN-? to macrophages. Anti-Mouse IFN gamma Antibody (H22) inhibits macrophage-activating factor (MAF) (ID50 = 56 ng). Anti-Mouse IFN gamma Antibody (H22) inhibits IFN-gamma dependent antiviral activity (ID50 = 2 ng). Anti-Mouse IFN gamma Antibody (H22) neutralizes IFN? in mice. Anti-Mouse IFN gamma Antibody (H22) can be used for the researches of inflammation and infection, such as arthritis[1][2][3][4]. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99136. | |
| Anti-Mouse PD-1 Antibody (RMP1-14) | Anti-Mouse PD-1 Antibody (RMP1-14) is an anti-mouse PD-1 IgG2a antibody. Anti-Mouse PD-1 Antibody (RMP1-14) can be used for the study of colon carcinoma[1]. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P99144. | |
| Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) | Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) is an anti-mouse PD-L1/B7-H1 IgG2b antibody inhibitor derived from host rat. Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) blocks PD-1 signaling. Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) can be used for the research of cancer, such as colon cancer[1]. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P99145. | |
| Anti-SEZ6 Antibody (SC17) | Anti-SEZ6 Antibody (SC17) is an anti-SEZ6 IgG1 monoclonal antibody. Anti-SEZ6 Antibody (SC17) can be used to synthesize antibody-drug conjugates (ADC) product, ABBV-011[1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: ABBV-011 antibody; ABBV-706 antibody. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P991041. | |
| Anti-TSHR Antibody (K1-70) | Anti-TSHR Antibody (K1-70) is a CHO-expressed human antibody that targets TSHR. Anti-TSHR Antibody (K1-70) has a huIgG1 heavy chain and a hu? light chain, with a predicted molecular weight (MW) of 143.54 kDa. For the isotype control of Anti-TSHR Antibody (K1-70), you can refer to Human IgG1 kappa, Isotype Control (HY-P99001). Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: K1-70. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990534. | |
| Anzurstobart | Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRP? antibody that blocks the binding of CD47 to SIRP?. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab (HY-P9913). Anzurstobart has the potential for solid and hematologic malignancies research[1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: CC-95251; BMS-986351. CAS No. 2543693-10-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990033. | |
| Apitegromab | Apitegromab (SRK-015) is an anti-promyostatin monoclonal antibody. Apitegromab can be used for the research of neuromuscular disease including spinal muscular atrophy [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: SRK-015. CAS No. 2278276-46-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99441. | |
| Ascrinvacumab | Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a K d value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC) [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-ACVRL1 / ALK-1 Reference Antibody (ascrinvacumab); PF-03446962. CAS No. 1463459-96-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99353. | |
| Asfotase alfa | Asfotase alfa (ENB-0040) is a bone-targeted genetically engineered glycoprotein. Asfotase alfa increases the survival rate, bone mineralization and bone length and prevents mineralization defects of the feet, rib cage, lower limbs, jaw bones in Akp2 / knockout mice. Asfotase alfa can be used for the research of perinatal, infantile, and juvenile-onset hypophosphatasia (HPP) [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: ENB-0040. CAS No. 1174277-80-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-108786. | |
| Astegolimab | Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2 , the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MSTT 1041A; RG 6149. CAS No. 2173054-79-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99444. | |
| Asunercept | Asunercept (APG101; CAN008) is a soluble CD95-Fc fusion protein targeting CD95L. Asunercept disrupts CD95/CD95L signaling by selectively binding to CD95L. Asunercept can be used in the research of glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD) [1] [2] [3]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: APG101; CAN008. CAS No. 1450882-18-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99445. | |
| Atacicept | Atacicept (TACI-Ig) is a is a recombinant fusion protein containing the extracellular, ligand-binding portion of the TACI receptor and the Fc portion of human IgG. Atacicept inhibits B cell stimulation by binding to B lymphocyte stimulator and a proliferation-inducing ligand. Atacicept can be used in research of B-cell autoimmune disease [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: TACI-Ig; TACI-Fc 5. CAS No. 845264-92-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99446. | |
| Atezolizumab | Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 ( PD-L1 ), used for cancer research. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MPDL3280A. CAS No. 1380723-44-3. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P9904. | |
| ATG-031 | ATG-031 is a humanized anti-CD24 monoclonal antibody with high affinity and specificity. ATG-031 interacts with Siglec-10 expressed by tumor-associated macrophages. ATG-031 effectively stimulates macrophage-mediated phagocytosis and induces cancer cell destruction by blocking the anti-phagocytic surface proteins. ATG-031 can be used in the study of haematological malignancies as well as solid tumors. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003)[1][2][3]. Uses: Scientific research. Group: Inhibitory antibodies. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99176. | |
| Atoltivimab | Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolaviru s ( EBOV s) infection [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: REGN3470. CAS No. 2135632-29-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99343. | |
| Atrosab | Atrosab is a humanized IgG1 antagonistic anti-TNFR1 antibody. Atrosab inhibits TNF-mediated Apoptosis induction and IL-6 and IL-8 production. Atrosab reduces neurological deficits. Atrosab can be used for research of inflammatory disease. The recommend isotype control is Human IgG1 kappa, Isotype Control (HY-P99001)[1][2][3]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 1365659-05-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990008. | |
| Avdoralimab | Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: IPH 5401; Anti-C5aR1 mAb. CAS No. 2226393-85-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99450. | |
| Avelumab | Avelumab is a fully human IgG1 anti- PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-Human PD-L1, Human Antibody; MSB 0010718C; MSB0010718C. CAS No. 1537032-82-8. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-108730. | |
| Avelumab (anti-PD-L1) | Avelumab (anti-PD-L1) is a fully human IgG1 anti- PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 1537032-82-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-108730A. | |
| Avizakimab | Avizakimab (BOS161721) is a humanized IgG1 monoclonal antibody that targets interleukin-21 [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: BOS161721. CAS No. 2229685-51-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99451. | |
| Axatilimab | Axatilimab (SNDX-6352) is a humanized IgG4 antibody with high affinity to CSF-1R. Axatilimab can be used for the research of chronic graft versus host disease (cGVHD) and neoplastic diseases [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: SNDX-6352. CAS No. 2155851-88-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99452. | |
Our database is helping our users find suppliers everyday.
